Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Gains from Sales and Divestitures (2020 - 2023)

Historic Gains from Sales and Divestitures for Cannabist Co Holdings (CBSTF) over the last 4 years, with Q4 2023 value amounting to $11.0 million.

  • Cannabist Co Holdings' Gains from Sales and Divestitures rose 19273.48% to $11.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $11.0 million, marking a year-over-year increase of 19273.48%. This contributed to the annual value of $11.0 million for FY2023, which is 19273.48% up from last year.
  • Per Cannabist Co Holdings' latest filing, its Gains from Sales and Divestitures stood at $11.0 million for Q4 2023, which was up 19273.48% from $5.7 million recorded in Q3 2023.
  • Cannabist Co Holdings' Gains from Sales and Divestitures' 5-year high stood at $11.0 million during Q4 2023, with a 5-year trough of $114957.0 in Q4 2021.
  • Its 4-year average for Gains from Sales and Divestitures is $3.4 million, with a median of $2.4 million in 2022.
  • In the last 5 years, Cannabist Co Holdings' Gains from Sales and Divestitures plummeted by 8101.97% in 2021 and then skyrocketed by 315885.42% in 2022.
  • Over the past 4 years, Cannabist Co Holdings' Gains from Sales and Divestitures (Quarter) stood at $605665.0 in 2020, then plummeted by 81.02% to $114957.0 in 2021, then soared by 3158.85% to $3.7 million in 2022, then skyrocketed by 192.73% to $11.0 million in 2023.
  • Its Gains from Sales and Divestitures was $11.0 million in Q4 2023, compared to $5.7 million in Q3 2023 and $5.5 million in Q2 2023.